Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss

A Fontalis, E Kenanidis, RA Kotronias… - … on Pharmacotherapy, 2019 - Taylor & Francis
… between bone resorption and accrual in osteoporosis include anti-… pharmacotherapy for
osteoporosis in women and explore state-of–the-art and emerging therapies to prevent bone loss

Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause

S Palacios, SP González… - … on Pharmacotherapy, 2024 - Taylor & Francis
… This review starts by summarizing the pathogenesis of postmenopausal osteoporosis (PMO),
with focus on the estrogen deficiency-associated bone loss. It continues with the current …

Pharmacological therapy of osteoporosis: what's new?

G Iolascon, A Moretti, G Toro, F Gimigliano… - … interventions in aging, 2020 - Taylor & Francis
Pharmacotherapy of osteoporosis is the main treatment option for these patients because
of strong evidence about the efficacy of available drugs targeting bone … reported bone loss. …

Developments in the pharmacotherapeutic management of osteoporosis

P Close, A Neuprez, JY Reginster - … Opinion on Pharmacotherapy, 2006 - Taylor & Francis
… and safety of lasofoxifene in osteoporotic women were presented in scientific meetings but
not yet released as full papers. In prevention of early bone loss, lasofoxifene was reported to …

New and developing pharmacotherapy for osteoporosis in men

L Gennari, JP Bilezikian - Expert opinion on pharmacotherapy, 2018 - Taylor & Francis
… mainly relates to traumatic fractures of the long bones (eg due to work-related …
osteoporosis-related fractures, evidence from prospective studies indicate that they may predict bone

Review of postmenopausal osteoporosis pharmacotherapy

SL Mayes - Nutrition in clinical practice, 2007 - Wiley Online Library
… of bone loss. This method of diagnosis is also used for the diagnosis of osteoporosis in male
… The BMD measurement is used to establish or confirm a diagnosis of osteoporosis and …

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

IEM Bultink, M Baden, WF Lems - … opinion on pharmacotherapy, 2013 - Taylor & Francis
… of bone loss and fractures in GC-treated patients and discusses current pharmacotherapy
and … Furthermore, clinical relevant issues such as adherence to anti-osteoporosis medication, …

Osteoporosis in older persons: current pharmacotherapy and future directions

G Duque - Expert opinion on pharmacotherapy, 2013 - Taylor & Francis
… This steady age-related bone loss alone does not necessarily predispose to osteoporotic
activity in combination with age-related bone loss increase the risk of fractures Citation[4]. …

Pharmacotherapy of osteoporosis in men

TH Diamond - Expert Opinion on Pharmacotherapy, 2005 - Taylor & Francis
… uncoupling in bone turnover and a net bone loss averaging … bone loss [24]. In addition to
the changes seen in cortical and cancellous bone, an age-related reduction in periosteal bone

Using sequential pharmacotherapy for the treatment of osteoporosis: an update of the literature

I Mondo, S Hannou, P D'Amelio - … Opinion on Pharmacotherapy, 2023 - Taylor & Francis
bone loss occurs. On the other hand, weight bearing exercises reduce the expression of SOST
and bone … finally results in increased bone formation and decreased bone resorption. By …